Xarelto and tooth extraction bleeding

Rivaroxaban is a direct oral anticoagulant that blocks Factor Xa in the clotting cascade. The effect on bleeding is similar to apixaban (Eliquis), with a slightly longer half-life (about 7 to 11 hours versus 8 to 12 hours for apixaban). Like other DOACs, the effect is predictable from dose to dose, and there is no routine lab test (like the INR for warfarin) that needs to be checked before procedures.

Rivaroxaban is commonly taken once daily, while Eliquis is usually taken twice daily. For higher-bleeding-risk procedures, that difference in dosing schedule affects how dose timing may be managed by the dental and prescribing team. This is a clinical decision that depends on the patient's dose schedule (morning versus evening), kidney function, age, and other medical factors — not something the patient implements independently.

Local bleeding control measures (sutures, gelfoam, oxidized cellulose, tranexamic acid mouthwash, direct pressure) work the same way on rivaroxaban as on any patient. The site bleeds slightly longer than in a non-anticoagulated patient, but bleeding is manageable in almost all cases without stopping the medication.